Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company. - MarketWatch
1. Hims & Hers stock dropped 32.61% due to collaboration termination. 2. Novo Nordisk cites 'deceptive promotion' of illegitimate Wegovy versions. 3. Stock faced biggest one-day loss since public debut in September 2019. 4. Hims & Hers had surged 125.5% post-collaboration announcement before drop. 5. Novo Nordisk's collaboration failure threatens Hims & Hers' market position.